Logo
CustomersBlogPricingDemo
SIGN UP NOWBOOK A DEMO

What is the Fiscal Year for Illumina?

Date: November 13, 2026


Illumina's current fiscal year starts on January 4, 2026, and ends on January 3, 2027. Their current quarter is Q4, which ends on January 3, 2027.

Current Fiscal Year Overview

Fiscal Year Start
January 4, 2026
Fiscal Year End
January 3, 2027
Current Quarter
Q4
Current Quarter End
January 3, 2027

Quarterly Breakdown

Q1

Jan 4, 2026 – Apr 3, 2026

Q2

Apr 4, 2026 – Jul 3, 2026

Q3

Jul 4, 2026 – Oct 3, 2026

Q4

Oct 4, 2026 – Jan 3, 2027

Company Information

Headquarters

San Diego, CA

Industry

Biotechnology Research

Stock Symbol

ILMN

Website
http://www.illumina.com
Description

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.


Use Salesmotion for Account Data and Insights

Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Illumina and uncover key business information that drives smarter conversations.

Book a demo today to strengthen your sales strategy with powerful data and actionable insights.

BOOK A DEMO